GlaxoSmithKline scraps float plans for HIV business
by Julia Kollewe and Sean Farrell from on (#8H0T)
Drugmaker decides to retain ViiV Healthcare as part of a plan to revive performance and boost growth in emerging markets
Continue reading...
Drugmaker decides to retain ViiV Healthcare as part of a plan to revive performance and boost growth in emerging markets
Continue reading...
| Source | RSS or Atom Feed |
| Feed Location | http://feeds.theguardian.com/theguardian/science/rss |
| Feed Title | |
| Feed Link | http://feeds.theguardian.com/ |
| Reply | 0 comments |